Posted on February 1, 2012 by Sitemaster
The full meeting agenda and abstracts for the upcoming Genitourinary Cancers Symposium (co-sponsored by ASCO and others) are now available on line. The prostate cancer session will start tomorrow morning in San Francisco; unfortunately we have not been able to send a reporter to this meeting this year.
You can scan the agenda and read abstracts of relevant prostate cancer studies if you click here.
The ?New? Prostate Cancer InfoLink will be looking through these abstracts and monitoring media reports with care over the next few days to see if we can spot any real ?pearls? of wisdom. We do already know that full data from the initial Phase III trial of MDV3100 (in men with metastatic castration-resistant prostate cancer who have been treated with at least one cycle of chemotherapy) are to be presented at this meeting for the first time.
Like this:
Be the first to like this post.
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment
stephen curry girl with the dragon tattoo hes just not that into you hes just not that into you monta ellis kawasaki disease mega millions
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.